Diffuse gliomas with FGFR3::TACC3 fusion have been mainly reported in the adult setting where they account for 3.1–11.8% of cases with pathological features of glioblastoma [4, 13, 22, 30, 31]. This evidence concerns the gene FGFR3 and central nervous system cancer.